Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.
Sci Transl Med. 2019 Aug 7;11(504):eaax7392. doi: 10.1126/scitranslmed.aax7392.
Sci Transl Med. 2019.
PMID: 31391323
Free PMC article.